Data showed that while, the normalized expression level of IL-17A underwent a down-regulation in both mild (P=0.332) and severe asthma (P=0.006) affected samples, only in severe asthma the expression was statistically significant in comparison with control group (Figure 1A). The gene discussed is IL17A; the disease is asthma.